Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00048009 · ClinicalTrials.gov registry record · Phase 2

Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids

A Phase 2 study of Asthma, sponsored by Hoffmann-La Roche.

Completed
Registry status
Phase 2
Development phase
20
Study locations

NCT00048009 is a Phase 2 study of Asthma that has completed, run by Hoffmann-La Roche. The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00048009, a Phase 2 study of Asthma, has completed, sponsored by Hoffmann-La Roche.

COMPLETED
Registry status
Phase 2
Development phase
20
Study locations

Study Summary

The purpose of this study is to determine the appropriate dose of Ro 27-2441 (test drug) to be used in future studies, assess the efficacy and safety, and the anti-inflammatory action of the test drug in the treatment of asthmatic patients who are not currently receiving chronic therapy with corticosteroids. The research is being conducted at up to 80 clinical research sites in the US, Mexico, and Canada. Study participants will have a number of visits to a research site over approximately a 4-month period.

Conditions Studied

Asthma

Interventions

  • DRUG Dual Integrin Antagonist

Study Locations (20)

California

  • - Huntington Beach
  • - Long Beach
  • - Los Angeles
  • - Los Angeles
  • - Palmdale
  • - San Diego
  • - San Diego
  • - San Diego
  • - San Jose
  • - Walnut Creek

Colorado

  • - Denver
  • - Denver
  • - Louisville
  • - Wheat Ridge

Florida

  • - Tallahassee
  • - Tamarac
  • - Tampa
  • - Tampa

Arizona

  • - Scottsdale

Connecticut

  • - Hartford

Trial Details

FieldValue
Start Date 2002-10-25
Est. Completion 2004-02-02
Phase Phase 2

Sponsor

Hoffmann-La Roche

909 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00048009

The ClinicalTrials.gov registry entry for NCT00048009 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Hoffmann-La Roche, which has 909 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Dual Integrin Antagonist is the first listed.

NCT00048009 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, Florida.

Frequently Asked Questions

What is clinical trial NCT00048009 about?

NCT00048009 is a clinical study titled "Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled Corticosteroids". The purpose of this study is to determine the appropriate dose of Ro 27-2441 (test drug) to be used in future studies, assess the efficacy and safety, and the anti-inflammatory action of the test drug in the treatment of asthmatic patients who are not currently receiving chronic therapy with cortico...

What is the current status of trial NCT00048009?

This trial is currently completed. It is a Phase 2 study. The study started on 2002-10-25. Estimated completion is 2004-02-02.

What conditions does trial NCT00048009 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00048009?

The interventions under investigation include: Dual Integrin Antagonist (DRUG).

Who is sponsoring clinical trial NCT00048009?

This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00048009 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.